Charles River, in association with Varigenix®, offers a new tool that has been validated to study the impact of genetic variation in pharmacogenomics and toxicogenomics. Varigenix® hepatocyte panels express genetic variability comparable to human populations and are available as four products. Each hepatocyte panel consists of ~1 million cryopreserved hepatocytes in suspension.
Hepatocyte Panels
The first panel is currently available for purchase and other panels will be produced to meet market demand.
|
Panel |
Strains in addition to parental strains C57BL/6J and DBA/2J |
|
1 |
Males of 22 BXD strains derived from Taylor series BXD1 to BXD42 |
|
2 |
Females of 22 BXD strains derived from Taylor series BXD1 to BXD42 |
|
3 |
Males of 22 BXD strains derived from BXD43 to BXD103 of the advanced UTHSC series |
|
4 |
Females of 22 BXD strains derived from BXD43 to BXD103 of the advanced UTHSC series |